Agreed. Worrying about dilution amongst expansion plans like this is counter intuitive. Any percentage impact of additional shares should pale in comparison to SP movements.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025